
Science Applications International Corporation SAIC will release its fourth-quarter financial results, before the opening bell, on Monday, March 17.
Analysts expect the Reston, Virginia-based company to report quarterly earnings at $2.09 per share, up from $1.43 per share in the year-ago period. Science Applications International projects quarterly revenue of $1.81 billion, compared to $1.74 billion a year earlier, according to data from Benzinga Pro.
On March 12, Science Applications International and Defense Unicorns disclosed a strategic partnership to increase the delivery of secure, scalable and mission-critical software capabilities for the Department of Defense.
Science Applications International shares fell 0.4% to close at $104.26 on Thursday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Wells Fargo analyst Matthew Akers maintained an Overweight rating and cut the price target from $149 to $139 on Feb. 26, 2025. This analyst has an accuracy rate of 68%.
- TD Cowen analyst Gautam Khanna downgraded the stock from Buy to Hold and cut the price target from $155 to $120 on Jan. 8, 2025. This analyst has an accuracy rate of 78%.
- JP Morgan analyst Seth Seifman maintained an Overweight rating and cut the price target from $170 to $148 on Dec. 6, 2024. This analyst has an accuracy rate of 80%.
- Citigroup analyst Jason Gursky maintained a Buy rating and raised the price target from $160 to $176 on Oct. 10, 2024. This analyst has an accuracy rate of 72%.
- Barclays analyst David Strauss maintained an Equal-Weight rating and increased the price target from $135 to $150 on Sept. 16, 2024. This analyst has an accuracy rate of 68%.
Considering buying SAIC stock? Here’s what analysts think:

Read This Next:
Momentum18.97
Growth33.18
Quality39.58
Value38.67
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.